EVALUATION OF THE IMPACT OF A PHARMACEUTICAL CARE SERVICE OFFERED TO PATIENTS SUFFERING ALLERGIC RHINITIS WITHIN AN AMBULATORY SETTING
Ana María Rodríguez-Peláez y Peña*
The objectives of the study were to evaluate the impact of a newly developed pharmaceutical care services directed to allergic rhinitis patients attending an out-patient setting. A total of 200 patients participated in the study and were randomly divided into two equal groups, Group A and Group B. The study was carried out over three phases. In phase 1, Group A patients were assessed and offered a pharmaceutical care session. Group B patients were assessed but no pharmaceutical care session was delivered. At phase 2 (4-6 months), group A patients were re- assessed (first assessment post pharmaceutical care plan). Group B patients were re-assessed a second time (second baseline assessment) and a pharmaceutical care session was offered to Group B patients. At phase 3 (time 10-11 months) both groups were re-assessed a third time. The newly developed individualised pharmaceutical care service provided by the pharmacist led to an improved quality of life as measured by the health-related quality of life questionnaires.
Keywords: Pharmaceutical care, Quality of life, Allergic rhinitis, Drug therapy problems, Pharmacist contribution.
[Full Text Article]